Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06315517 · ClinicalTrials.gov registry record · NA
Double Crossover Casein Type Tolerance Trial
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT06315517: Completed NA study, sponsored by Auburn University.
NCT06315517 is a NA study that has completed, run by Auburn University. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06315517, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.
Primary Outcome
Changes in gastrointestinal distress measured via visual analog scales that range from 0 (no symptoms) to 100 cm (severe symptoms). Lower values are optimal.
Interventions
- OTHER Conventional lactose-free cow's milk
- OTHER Nonconventional (A2) cow's milk
- OTHER Nonconventional (A2) lactose-free cow's milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-04-20 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What the finished NCT06315517 record still lists
NCT06315517 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Conventional lactose-free cow's milk is the first listed.
NCT06315517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06315517 about?
NCT06315517 is a clinical study titled "Double Crossover Casein Type Tolerance Trial". The investigators will recruit 45 fluid milk avoiding adults to participate in a five-week double-blind, double-crossover study in which the physiological responses to increasing doses of lactose-free (A1-rich milk), A2 milk, and lactose-free A2 milk will be explored.
What is the current status of trial NCT06315517?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2024-04-20. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT06315517?
The interventions under investigation include: Conventional lactose-free cow's milk (OTHER), Nonconventional (A2) cow's milk (OTHER), Nonconventional (A2) lactose-free cow's milk (OTHER).
Who is sponsoring clinical trial NCT06315517?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06315517's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI